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Growing use of cloud computing in clinical trials prompted the European Clinical Research Infrastructures Network,
a European non-profit organisation established to support multinational clinical research, to organise a one-day
workshop on the topic to clarify potential benefits and risks. The issues that arose in that workshop are summarised
and include the following: the nature of cloud computing and the cloud computing industry; the risks in using
cloud computing services now; the lack of explicit guidance on this subject, both generally and with reference to
clinical trials; and some possible ways of reducing risks. There was particular interest in developing and using a
European ‘community cloud’ specifically for academic clinical trial data. It was recognised that the day-long
workshop was only the start of an ongoing process. Future discussion needs to include clarification of trial-specific
regulatory requirements for cloud computing and involve representatives from the relevant regulatory bodies.
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Recent years have seen rapidly growing interest in ‘cloud
computing’, driven by the promise of cheap and flexible in-
formation technology (IT) infrastructure available as a ser-
vice, reducing the requirements for in-house systems and
staff. Trials units and vendors of clinical data management
systems (CDMSs) are not immune to these temptations.
Moreover, there are use cases in which cloud computing
may be a good fit (for instance, the aggregation of data for
meta-analysis or the long-term curation of trial data).
Within ECRIN-IA, an EU Seventh Framework Programme
(FP7)-funded project, the European Organisation for
Research and Treatment of Cancer is developing VISTA
Trials, based on an existing widely used CDMS. The
current need to explore options for this system’s deploy-
ment serves as ECRIN’s own use case.
The difficulty is that cloud computing technology brings
risks as well as benefits. We need a better understanding
of both, and we need to engage regulators to clarify the
criteria by which cloud computing services can be judged.* Correspondence: christian.ohmann@med.uni-duesseldorf.de
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Brussels, Belgium) to instigate this process, and this com-
mentary summarises the points that emerged that day.
Main text
The commentary is based on a workshop. For that rea-
son, no ethical approval was required and no informed
consent obtained.
What is ‘cloud computing’?
We see cloud computing as an extension of traditional
outsourced IT provision, but confusion still surrounds
what the term ‘cloud computing’ means. We use the Na-
tional Institute of Standards and Technology definition
[1]: user-managed service configuration, rapid scalability
and elasticity, and a metered cost model.
The industry is growing very rapidly [2], exhibits fierce
competition with (until very recently) rapidly decreas-
ing costs [3], and is dominated by US-based companies,
in particular Amazon (Seattle, WA, USA) and Microsoft
Corporation (Redmond, WA, USA) but also Google
(Mountain View, CA, USA) and IBM Corporation
(Armonk, NY, USA) [4].
Though open or public clouds are the most common,
it is possible to have cloud services limited to particulararticle distributed under the terms of the Creative Commons Attribution License
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organisation (a ‘private cloud’). There is growing interest
in so-called ‘hybrid clouds’, denoting a mix of private
and public or community cloud services.
Possible risks
The meeting identified the following major risks in using
cloud computing:
 Lack of control: Cloud computing involves plugging
into pre-existing services rather than negotiating
bespoke provision. Many services (e.g., the provision
of redundant copies of data to maintain availability)
are managed invisibly by the cloud provider. A trials
unit may not control the countries in which its data
is stored, even though data crossing international
borders can generate additional legal and regulatory
obligations. Data that a unit believes to have been
deleted may still be retained somewhere by the
cloud service [5]. Cloud users should be aware
that cloud service providers may not be held
contractually responsible for hosting poorly
designed systems [6].
 Industry volatility: Fierce competition means that
several cloud providers are likely to disappear in the
next few years. It is not clear how this could affect
subsequent access to data. Data lock-in makes it
difficult for a customer to migrate from one provider
to another or migrate data and services back
in-house [7].
 Security: Cloud providers put considerable resources
into security but are also obvious targets for those
wishing to steal data. This no longer involves
‘amateur’ hacking; it is a sophisticated criminal
activity, with trial data being viewed as having a
re-sale value. In addition, in the cloud, it is not
always clear who is responsible for different aspects
of security. There is a risk of security controls ‘falling
through the cracks’ if the customer is not fully aware
of their role. The situation may get even more
critical if clinical trials are linked to biobanks,
and the question needs to be addressed how to
handle the even more sensitive molecular data if
anonymisation cannot be performed.
 Suitability: Individual clinical trial datasets rarely
exceed a few gigabytes and are fixed once the trial is
over. They are stored for archiving and audit rather
than reuse and updating. There is a risk that the
costs for cloud provisioning of such basic services
could overtake the costs of delivering them via
conventional means.
 Uncertainties over legal jurisdictions: As recent court
cases have demonstrated [8], there is continued
uncertainty about the legal frameworks that apply tocloud data. Data may be sited within and also move
through—via routers, switches, and satellites—a variety
of countries. In this context, a range of issues, most
conspicuously the application of EU versus non-EU
data access regulations, still await clarification.
 Lack of knowledge: Hosting offered by CDMS vendors
and others for trial data increasingly involves cloud
computing facilities. Hosts are often unclear, however,
about the exact cloud computing arrangements,
making it much more difficult for the unit to
investigate and demonstrate regulatory compliance.
Lack of compliance guidelines
Compounding the problems listed above is the lack of
regulatory guidance. The cloud-specific International
Organization for Standardization (ISO) standard (27017)
currently at the FDIS (final draft international standard)
approval stage (ISO 27018 has recently been approved).
There are general ‘Service Organization Control’ standards
in the US but these have limited applicability in Europe.
Other systems being developed include the Cloud Security
Alliance’s Security, Trust & Assurance Registry (STAR)
system [9], but take-up of this appears limited.
At present, there appears to be little Good Clinical
Practice-specific guidance on using cloud services. ECRIN
is among the organizations that need to address this issue,
reviewing their own standards for data centre certification
[10] in the light of possible cloud computing usage.
Reducing risks
The following were identified as possible ways of redu-
cing risks:
 Identify requirements: It is important to be clear why
a cloud computing solution is preferable to a
traditional arrangement and to identify the specific
requirements within that solution.
 Assess options by using a risk-based approach: All
types of risks (technical, legal, and organisational)
should be assessed to identify vulnerabilities,
threats, and mitigations [7, 11].
 Have explicit contracts: Ideally, once requirements
are identified, they should be incorporated into the
purchased services through explicit contracts:
providers who cannot provide and prove these
specific requirements should be avoided. There
should be an option that a customer or a third
party may carry out tests and audits [11].
 Use encryption at source: Particularly for public
clouds, one way of guaranteeing privacy is to
encrypt all data ‘at source’ (i.e., under the control of
the trials unit rather than the cloud provider).
However, the systems, time, and money required for
effective encryption key management should not be
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governmental attitudes toward the public use of
encryption systems in the EU nations.
 Develop European Community clouds: Using
community clouds (e.g., restricted to universities in
Europe) would be one way of alleviating some of the
security/control risks of public clouds. If they were
based in and managed by European institutions,
there would also be no question that they fell into a
European jurisdiction for data protection purposes.
 In this context, there was considerable interest in
using the ‘federated cloud’ approach of the European
Grid Infrastructure (EGI) project [12], which makes
use of a distinct physical infrastructure (Géant) [13]
for communicating between nodes and is actively
policed for security breaches. It was felt that a
‘mini-EGI’ established specifically for trial data could
realise many of the benefits of cloud computing with
reduced risk, although it was recognised that there
would be many practical hurdles to overcome.
Another innovative approach, described in the
workshop, used a peer-to-peer network to share
resources between trials units and clinical sites.
Conclusions
The ECRIN workshop was a beginning; there were more
questions raised than questions answered. Trials units
need time to understand cloud computing and consider
the risks and benefits. Technology is developing rapidly
and becoming cheaper, more tempting, more widely used,
and therefore possibly more dangerous. We urgently need
to characterise the acceptable use of cloud computing for
clinical trials. We also need to explore the options for
developing a community cloud facility specifically for clin-
ical trial data. ECRIN is keen to engage with other organi-
sations and agencies in the pursuit of those goals. The
next concrete step will be to perform a follow-up work-
shop with experienced clinical trial and IT experts and
representatives from regulatory authorities, ethics com-
mittees, and data protection organisations with the target
to clarify trial-specific regulatory requirements for cloud
computing and to explore consequences for the ECRIN
data centre certification programme.
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